The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseases

被引：7

作者：

Lories, RJU ^{[1
]}

Maertens, JA ^{[1
]}

Ceuppens, JL ^{[1
]}

Peetermans, WE ^{[1
]}

机构：

[1] Catholic Univ Leuven, Univ Hosp, Dept Internal Med Rheumatol, Louvain, Belgium

来源：

ACTA CLINICA BELGICA | 2000年 / 55卷 / 03期

关键词：

D O I：

10.1080/17843286.2000.11754288

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this review we discuss the prevention and treatment of infectious diseases with intravenous immunoglobulins (IVIG). IVIG can be used to prevent infections in primary as well as in certain secondary immunodeficiencies. We also discuss the use of IVIG in the prevention of CMV-disease after organ or bone marrow transplantation. Besides their use in prevention, IVIG can also be used as an additional therapy in sepsis in neonates, in streptococcal toxic shock syndrome and in CMV-disease after bone marrow or solid organ transplantation. We briefly discuss the different preparations of IVIG that are available in Belgium.

引用

页码：163 / 169

页数：7

共 50 条

[1] Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases
Hemming, VG
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (05) : 859 - 863
[2] Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases
Hsu, Jennifer L.
Safdar, Nasia
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2011, 25 (04) : 773 - +
[3] To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock
Neugebauer, Edmund A. M.
CRITICAL CARE MEDICINE, 2007, 35 (12) : 2855 - 2856
[4] Human polyclonal immunoglobulins for intravenous use and transplantation
Haymann, JP
Glotz, D
INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 237 - 242
[5] Human polyclonal immunoglobulins for intravenous use and transplantation
Haymann, JP
Glotz, D
NEPHROLOGIE, 1999, 20 (03): : 139 - 143
[6] Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders
Graff-Dubois, Stephanie
Siberil, Sophie
Elluru, Sriramulu
Negi, Vir-Singh
Delignat, Sandrine
Mouthon, Luc
Lacroix-Desmazes, Sebastien
Kazatchkine, Michel D.
Bayary, Jagadeesh
Kaveri, Srini V.
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2007, 14 (01) : 63 - 68
[7] Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases
Kim, Kyung-Hyo
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2008, 51 (12): : 1151 - 1157
[8] Intravenous immunoglobulins in infectious diseases: where do we stand?
Mouthon, L
Lortholary, O
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (05) : 333 - 338
[9] Use of intravenous immunoglobulins in neurological diseases: An update
Stangel, M.
Gold, R.
AKTUELLE NEUROLOGIE, 2007, 34 (06) : 342 - 347
[10] Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes
Stangel, M
Compston, A
Scolding, NJ
JOURNAL OF NEUROIMMUNOLOGY, 1999, 96 (02) : 228 - 233

← 1 2 3 4 5 →